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An inducible phenylserine aldolase (L-threo-3-phenylserine benzaldehyde-lyase, EC 4.1.2.26), which catalyzes
the cleavage of L-3-phenylserine to yield benzaldehyde and glycine, was purified to homogeneity from a crude
extract of Pseudomonas putida 24-1 isolated from soil. The enzyme was a hexamer with the apparent subunit
molecular mass of 38 kDa and contained 0.7 mol of pyridoxal 5 phosphate per mol of the subunit. The enzyme
exhibited absorption maxima at 280 and 420 nm. The maximal activity was obtained at about pH 8.5. The
enzyme acted on L-threo-3-phenylserine (Km, 1.3 mM), L-erythro-3-phenylserine (Km, 4.6 mM), L-threonine (Km,
29 mM), and L-allo-threonine (Km, 22 mM). In the reverse reaction, threo- and erythro- forms of L-3-phenyl-
serine were produced from benzaldehyde and glycine. The optimum pH for the reverse reaction was 7.5. The
structural gene coding for the phenylserine aldolase from Pseudomonas putida 24-1 was cloned and overex-
pressed in Escherichia coli cells. The nucleotide sequence of the phenylserine aldolase gene encoded a peptide
containing 357 amino acids with a calculated molecular mass of 37.4 kDa. The recombinant enzyme was
purified and characterized. Site-directed mutagenesis experiments showed that replacement of K213 with Q
resulted in a loss of the enzyme activity, with a disappearance of the absorption maximum at 420 nm. Thus,
K213 of the enzyme probably functions as an essential catalytic residue, forming a Schiff base with pyridoxal
5-phosphate.
Much attention has been paid to 3-hydroxy-2-amino acids as
components of antibiotics and immunosuppressants (5–7, 9,
18, 19, 32–34) and as a drug for Parkinson’s disease therapy
(21), and enzymatic syntheses of 3-hydroxy-2-amino acids with
L- and D-threonine aldolases have been done extensively (5, 6,
9, 18, 19, 32–34).
Phenylserine aldolase (L-threo-3-phenylserine benzaldehyde-
lyase, EC 4.1.2.26) catalyzes the reversible conversion of L-
threo- and L-erythro-3-phenylserine to benzaldehyde and gly-
cine. Although the occurrence of phenylserine aldolase in an-
imals has been reported previously (2), the enzyme has not
been purified and characterized. Since serine hydroxymethyl-
transferase (SHMT) (27, 28, 30) and threonine aldolase (13–
16) show the phenylserine aldolase activity, it has been thought
that the phenylserine aldolase activity is due to SHMT or
threonine aldolase. During the course of a study on microbial
metabolism of DL-threo-3-phenylserine, we found a phenyl-
serine aldolase activity in a soil bacterium identified as Pseudo-
monas putida 24-1. To use the enzyme for the synthesis of
3-hydroxy-2-amino acids, we purified the enzyme to homoge-
neity from the bacterium and obtained evidence that the en-
zyme is an inducible phenylserine aldolase but not SHMT and
threonine aldolase.
This paper presents the first identification of phenylserine
aldolase from P. putida 24-1 and its enzymologic characteristics
as well as cloning and overexpression of its gene in Escherichia
coli.
MATERIALS AND METHODS
Materials. DL-threo-3-Phenylserine, DL-threo-3-hydroxynorvaline, L-threonine,
D-threonine, L-allo-threonine, D-allo-threonine, L-serine, D-serine, and DL-3-hy-
droxyphenylethylamine were obtained from Sigma, St. Louis, MO. DEAE-cel-
lulose was supplied by Serva, Heidelberg, Germany. A Mono Q HR10/10 column
was obtained from Pharmacia, Uppsala, Sweden, and a YMC-Pack C4 column
was purchased from YMC, Kyoto, Japan. DL-erythro-3-Phenylserine was synthe-
sized according to the method of Greenstein and Winitz (4). D-threo-3-Phenyl-
serine was prepared from its DL isomer with phenylserine dehydratase (26).
Other chemicals used were of analytical grade.
Medium and culture conditions. The bacterium was cultured with a medium
(pH 7.2) containing 1.0% peptone, 0.2% DL-threo-3-phenylserine, 0.2% K2HPO4,
0.2% KH2PO4, 0.2% NaCl, 0.01% MgSO4 · 7H2O, and 0.01% yeast extract.
Large-scale cultivation was carried out in 2-liter flasks containing 500 ml of the
medium at 30°C for 12 h on a reciprocal shaker. The cells were harvested by
centrifugation and washed twice with 0.85% NaCl. E. coli clones were grown
aerobically at 37°C for 20 h in 100 ml of a Luria-Bertani (LB) medium (1%
peptone, 0.5% yeast extract, and 0.5% NaCl, pH 7.2) supplemented with ampi-
cillin (50 g/ml) and isopropyl--D-thiogalactopyranoside (IPTG; 100 g/ml).
Enzyme assay. The standard reaction mixture contained 10 mol of DL-threo-
3-phenylserine, 10 nmol of pyridoxal 5-phosphate (PLP), 100 mol of N-tris(hy-
droxymethyl)methyl-3-aminopropanesulfonic acid (TAPS) buffer (pH 8.5), and
enzyme in a final volume of 0.5 ml. In a blank, the enzyme was replaced with
water. Incubation was performed at 30°C for 10 min. The reaction was stopped
by the addition of 0.5 ml of 1 M HCl. The benzaldehyde formed was determined
by the 2,4-dinitrophenylhydrazine method as follows. To the reaction mixture
(0.55 ml), 0.15 ml of 0.1% 2,4-dinitrophenylhydrazine solution in 2 M HCl was
added, and the mixture was incubated at 30°C for 20 min. Three milliliters of
99% ethanol and 0.85 ml of 3 M NaOH were then added to the mixture, and the
color intensity of 2,4-dinitrophenylhydrazone of benzaldehyde was measured at
475 nm with a Shimadzu UV-1200 spectrophotometer. One unit of the enzyme
was defined as the amount that catalyzed the formation of 1 mol of benzalde-
hyde per minute in the reaction. Specific activity was expressed as units per
milligram of protein. Protein was measured by the method of Lowry et al. (20)
with bovine serum albumin as the standard. Concentrations of the purified
enzyme were determined from the absorbance at 280 nm. The absorption coef-
ficient (A1 cm1% cm at 280 nm  11.9) was estimated by absorption and dry weight
determinations.
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The threonine aldolase and allo-threonine aldolase activities were measured
by estimation of acetaldehyde with yeast alcohol dehydrogenase. The formation
of L-3-phenylserine from benzaldehyde and glycine was examined as follows. The
reaction mixture (0.5 ml), containing 5 mol of benzaldehyde, 50 mol of
glycine, 10 nmol of PLP, 100 mol of Tris-HCl buffer (pH 7.5), and enzyme, was
incubated at 30°C for 10 min. After termination of the reaction by the addition
of 0.1 ml of 25% trichloroacetic acid, the mixture was centrifuged. The pH of the
supernatant was adjusted to 5.0 and filled up to 5.0 ml with a 0.5 mM CuSO4
solution. A sample (50 l) was analyzed by high-performance liquid chromatog-
raphy (HPLC) with a TSK gel Enantio L1 column (0.46 by 25 cm) (24).
Purification of phenylserine aldolase. All procedures were performed at 0 to
5°C, and N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES) buffer
(pH 7.2) containing 0.01% 2-mercaptoethanol, 1 mM EDTA disodium salt
(EDTA), and 50 M PLP was used in the purification procedures unless other-
wise stated.
Washed cells (289 g, wet weight) were suspended in 300 ml of 0.1 M buffer (pH
7.2) containing 0.02% 2-mercaptoethanol, 2 mM EDTA, and 50 M PLP and
disrupted by sonication. The supernatant obtained by centrifugation was dialyzed
overnight against 10 mM buffer (pH 7.2) and used as the crude extract.
The crude extract was brought to 40% ammonium sulfate saturation. After
being kept for 1 h, the precipitate was removed by centrifugation. To the super-
natant, solid ammonium sulfate was added to 60% saturation and left for 1 h.
The precipitate collected by centrifugation was dissolved in 10 mM buffer (pH
7.2) and dialyzed overnight against the same buffer. The enzyme solution was
applied to a DEAE-cellulose column (4.5 by 38 cm) equilibrated with 10 mM
buffer (pH 7.2). After the column had been washed thoroughly with the buffer
and then with the buffer supplemented with 0.1 M KCl, the enzyme was eluted
with the buffer supplemented with 0.15 M KCl. The active fractions were com-
bined and concentrated by ultrafiltration with a Pellicon Labocassete (Nihon
Millipore, Tokyo, Japan) equipped with PT filters. The enzyme solution was
dialyzed overnight against 10 mM potassium phosphate buffer (pH 7.2) contain-
ing 0.01% 2-mercaptoethanol, and 50 M PLP and applied to a hydroxyapatite
column (1.7 by 18 cm) equilibrated with 10 mM potassium phosphate buffer (pH
7.2) containing 0.01% 2-mercaptoethanol and 50 M PLP. After the column had
been washed with the buffer, the enzyme was eluted with 20 mM potassium
phosphate buffer (pH 7.2) containing 0.01% 2-mercaptoethanol and 50 M PLP.
The active fractions were concentrated with an Amicon 200 ultrafiltration unit
(Amicon, Lexington, MA) equipped with a PM-10 membrane filter and dialyzed
against 10 mM TES buffer (pH 7.2). The enzyme solution was applied to a
DEAE-cellulose column (1.7 by 19 cm) equilibrated with 10 mM TES buffer (pH
7.2). After the column had been washed thoroughly with the buffer and then with
the buffer supplemented with 0.1 M KCl, the enzyme was eluted with the buffer
supplemented with 0.15 M KCl. The active fractions were pooled and concen-
trated by ultrafiltration with the Pellicon Labocassete. The enzyme solution was
dialyzed overnight against 10 mM potassium phosphate buffer (pH 7.2) contain-
ing 0.01% 2-mercaptoethanol and 50 M PLP. The enzyme solution was applied
to a hydroxyapatite column (1.7 by 18 cm) equilibrated with 10 mM potassium
phosphate buffer (pH 7.2) containing 0.01% 2-mercaptoethanol and 50 M PLP.
After the column had been washed with the buffer, the enzyme was eluted with
30 mM potassium phosphate buffer (pH 7.2) containing 0.01% 2-mercaptoetha-
nol and 50 M PLP. The active fractions were concentrated with the Amicon 200
ultrafiltration unit and dialyzed against 10 mM TES buffer (pH 7.2). The enzyme
solution was applied to a Mono Q HR10/10 anion-exchange column (1.0 by 10
cm) equilibrated with 10 mM buffer (pH 7.2). The column was equipped with a
Pharmacia fast protein liquid chromatography system and developed at room
temperature at a flow rate of 1.0 ml/min with a 50-min linear gradient of KCl (0.2
to 0.35 M) in the same buffer. The active fractions were concentrated with the
Amicon 200 ultrafiltration unit, dialyzed against 10 mM buffer (pH 7.2), and
stored at 20°C in the presence of 30% glycerol.
Determination of molecular mass. The molecular mass was estimated by gel
filtration on a TSK gel G3000SW column (0.75 by 60 cm) at a flow rate of 0.7
ml/min with 0.1 M potassium phosphate buffer (pH 7.0) containing 0.2 M NaCl.
A calibration curve was made with the following proteins (Oriental Yeast Co.,
Osaka Japan): yeast glutamate dehydrogenase (290 kDa), pig heart lactate de-
hydrogenase (142 kDa), yeast enolase (67 kDa), yeast adenylate kinase (32 kDa),
and horse cytochrome c (12.4 kDa). The molecular mass of the subunit was
estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) (12), using the following marker proteins (Nacalai Tesque, Kyoto, Ja-
pan): rabbit muscle myosin (200 kDa), -galactosidase (116 kDa), bovine serum
albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (31 kDa), trypsin
inhibitor (21.5 kDa), and lysozyme (14.4 kDa).
Determination of the PLP content. The PLP content of the enzyme was
determined by the phenylhydrazine and cyanohydrin methods. For the phenyl-
hydrazine method, the enzyme (20 nmol) was kept at 37°C for 30 min in the
presence of 0.2 N HCl to release the bound cofactor and the amount of free PLP
was determined by using the method of Wada and Snell (35). For the cyanohy-
drin method, the enzyme sample (2 nmol) was hydrolyzed with a 55 mM H2SO4
solution at 120°C for 5 h and analyzed by the method of Bonavita (1).
Isolation of peptides obtained by tryptic digestion of the enzyme. The purified
enzyme (1 nmol) was dialyzed against water and lyophilized. The protein was
dissolved in 20 l of 0.4 M ammonium bicarbonate buffer (pH 8.0) containing 8
M urea, incubated at 37°C for 30 min, and then diluted with 60 l of water.
Trypsin was added to the solution in a 1:50 (mol/mol) ratio of protease to
substrate. Digestion was performed at 37°C for 24 h. The peptides were sepa-
rated on a Shimadzu HPLC system equipped with a YMC-Pack C4 column using
a solvent system of 0.1% trifluoroacetic acid (solvent A) and acetonitrile con-
taining 0.07% trifluoroacetic acid (solvent B). A 90-min linear gradient from 5 to
50% solvent B was used to elute peptides at a flow rate of 1.0 ml/min. The
absorbance at 210 nm of the effluent was continuously monitored. The peptides
were isolated and lyophilized.
Isolation of C-terminal peptide of the enzyme. The C-terminal peptide (P6)
was obtained with a Shimadzu CTFF-1 automatic C-terminal fragment fractiona-
tor after digestion of the enzyme with lysyl endopeptidase (3).
Amino acid sequence analysis. The amino acid sequence was determined with
an Applied Biosystems model 492 protein sequencer linked with a phenylthio-
hydantoin derivative analyzer.
Cloning and sequencing of the gene coding for phenylserine aldolase. The
chromosomal DNA of P. putida 24-1 was prepared by the method of Saito and
Miura (29). Sense (S) and antisense (A) primers were designed on the basis of
the amino acid sequences of the peptide P1, which was obtained from the tryptic
digest of the enzyme, and the C-terminal peptide (P6), respectively. Sequences
were 5-GGGAATTCAGGCGGGCCCGTATGGCACCGACGA-3 (primer S
containing an EcoRI site [underlined]) and 5-GGGGATCCCCAGCGGGTC
GTGATAGAAGCCGAA-3 (primer A containing a BamHI site [underlined]).
PCR was done with AmpliTaq DNA polymerase (Perkin-Elmer, Boston, MA).
The nucleotides of the amplified DNA fragment (880 bp) were sequenced with
an Applied Biosystems 373 DNA sequencer and a DNA sequencing kit (ABI
Prism dye terminator cycle sequencing ready reaction kit; Perkin Elmer). From
the sequence obtained, oligonucleotide probes U (5-TGATGACCGTCGACG
GCCCG-3) and C (5-CGGCCTTCAGCAGCGCATCGA-3) were prepared
and labeled with 32P with a DNA labeling kit (MEGALABEL; Takara Shuzo),
T4 polynucleotide kinase, and [-32P]ATP. The chromosomal DNA of P. putida
24-1 was digested with various restriction enzymes at 37°C overnight and elec-
trophoresed on a 0.7% agarose gel. The DNA fragments were transferred onto
a nylon membrane (GeneScreen Plus; DuPont Company, Wilmington, DE) by
blotting with a Pharmacia VacGene XL instrument. The blotted DNAs were
hybridized with radioactive probes U and C. Hybridization was done at 50°C and
monitored by autoradiography of the blotted DNA.
Cloning of the phenylserine aldolase gene. The SphI fragments (6.7 kb), which
hybridized with the radioactive probes U and C, were collected from the 0.7%
agarose gel by centrifugation in a SUPREC-01 tube and ligated into the SphI site
of pUC19. The ligated DNA was inserted into E. coli JM109 cells. Transformants
were selected on LB agar plates containing ampicillin (50 g/ml), IPTG (120
g/ml), and 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-Gal; 100 g/
ml). A positive clone was selected from the transformants by colony hybridiza-
tion with the radioactive probe U. A plasmid isolated from the positive clone was
named pPSA. The sequence of the gene for the enzyme in the plasmid pPSA was
analyzed in both directions.
To obtain a high expression strain, the structural gene for the enzyme was
amplified by PCR with Ex Taq DNA polymerase and with a sense primer
containing a EcoRI site (underlined) (5-GGGAATTCGACCATCAGGC
GAGCGTCAA-3) and an antisense primer containing a HindIII site (under-
lined) (5-GGAAGCTTCCAGAGCGAGCACAGCCGCCAC-3). The ampli-
fied DNA fragment was ligated into the EcoRI-HindIII site of pKK223-3. The
constructed plasmid was named pKPSA.
Purification of recombinant enzyme from E. coli cells. To purify the recom-
binant enzyme from E. coli cells, all procedures were performed at 0 to 5°C, and
the buffer containing 0.01% 2-mercaptoethanol, 1 mM EDTA, and 50 M PLP
was used, unless otherwise stated.
E. coli JM109 cells carrying pKPSA were cultured aerobically at 37°C for 24 h
in LB medium containing ampicillin (50 g/ml) and IPTG (120 g/ml). The cells
(8 g, wet weight) were suspended in 30 ml of 0.1 M TES buffer (pH 7.2)
containing 0.02% 2-mercaptoethanol, 2 mM EDTA, and 50 M PLP and dis-
rupted by sonication for 10 min. The supernatant obtained by centrifugation was
dialyzed overnight against 10 mM TES buffer (pH 7.2) and used as the crude
extract. To the crude extract, solid ammonium sulfate was added to 40% satu-
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ration with stirring. After 1 h, the precipitate was collected by centrifugation,
dissolved in 10 mM TES buffer (pH 7.2), and dialyzed overnight against the same
buffer. The enzyme solution was loaded onto a DEAE-Toyopearl column (3 by
15 cm) equilibrated with 10 mM TES buffer (pH 7.2). After the column had been
washed with 10 mM TES buffer (pH 7.2) containing 0.1 M KCl, the enzyme was
eluted with the buffer containing 0.125 M KCl. The active fractions were col-
lected, concentrated with an Amicon PM-10 membrane, and dialyzed overnight
against 10 mM potassium phosphate butter (pH 7.2). The enzyme solution was
applied to a hydroxyapatite column (2 by 10 cm) equilibrated with 10 mM
potassium phosphate butter (pH 7.2). After the column had been washed with 50
mM potassium phosphate buffer (pH 7.2), the enzyme was eluted with 0.1 M
potassium phosphate buffer (pH 7.2). The active fractions were collected, con-
centrated with an Amicon ultrafiltration unit with a PM-10 membrane, and
stored at 20°C in the presence of 50% glycerol until use.
Site-directed mutagenesis. Mutant enzymes, K213Q and K238Q, were pre-
pared according to the method of Kunkel et al. (11). The substitutions were
confirmed by DNA sequencing. The mutant enzymes were produced in E. coli
JM109 cells and purified by the same procedure as that used for the recombinant
enzyme.
Nucleotide sequence accession number. The nucleotide sequence data have
been deposited in the DDBJ/EMBL/GenBank nucleotide sequence databases
under accession number AB191192.
RESULTS
Isolation of a bacterium having an inducible phenylserine
aldolase. We isolated 22 strains of soil bacteria that could use
L-threo-3-phenylserine as the sole carbon and nitrogen source.
Crude extracts of 8 strains showed phenylserine aldolase ac-
tivity. Among these bacteria, strain 24-1 had the highest activ-
ity. Strain 24-1 was a gram-negative, aerobic, motile, and non-
sporing bacterium. It was a rod-shaped cell with polar flagella.
The degradation of protocatechuate was of the ortho type. The
16S ribosomal DNA sequence of the strain showed similarity
of 99.4% to that of Pseudomonas putida. Therefore, we named
this strain P. putida 24-1. We investigated the culture condi-
tions for aldolase production using P. putida 24-1. The enzyme
production was induced by the addition of 0.5% DL-threo-3-
phenylserine into a 1% peptone medium. However, L-threo-
nine, D-threonine, L-serine, D-serine, and glycine did not affect
enzyme production. The highest specific and total activities
were obtained by cultivating the cells in a 1% peptone medium
containing 0.5% DL-threo-3-phenylserine at 30°C for 12 h on a
reciprocal shaker.
Purification and molecular mass of phenylserine aldolase.
A typical summary of the purification procedure is shown in
Table 1. The enzyme was purified 440-fold with a 10% yield
from the crude extract. The purified enzyme showed a single
band on SDS-PAGE (Fig. 1A). The molecular mass of the
enzyme was estimated to be about 210 kDa by gel filtration on
a TSK gel G3000SW column. The molecular mass of the sub-
unit was calculated to be 38 kDa by SDS-PAGE. These results
suggest that the enzyme is a hexamer composed of identical
subunits.
Stability and optimum pH. The enzyme could be stored at
20°C in 10 mM TES buffer (pH 7.2) containing 0.01% 2-mer-
captoethanol, 50 M PLP, and 30% glycerol for several
months without any apparent loss of activity. When heated for
10 min in 10 mM TES buffer (pH 7.2), the enzyme was stable
up to 45°C. The enzyme was most stable in the pH range of 6.5
to 9.5 when kept at 30°C for 10 min. The enzyme showed
maximal activity at about pH 8.5 and high activity at pH 8.0 to
9.0.
Substrate specificity. The enzyme was specific for the L form
of threo- and erythro-3-phenylserine, and the D enantiomers
were not substrates. When DL-threo-3-phenylserine or DL-
erythro-3-phenylserine was used, analysis of the reaction mix-
ture by HPLC with a TSK gel Enantio L1 column proved that
only the L form was a substrate. The addition of D-threo-3-
phenylserine (10 mol) to the standard reaction mixture did
not affect the enzyme activity, showing that the D form of 3-phe-
nylserine did not inhibit the reaction. L-Threonine and L-allo-
threonine served as substrates, though only slightly (Table 2). The
enzyme did not act on L-serine, D-serine, D-threonine, D-allo-
threonine, DL-3-hydroxyphenylethylamine, DL-2-amino-3-phenyl-
n-butanoate, L-3-phenyllactate, DL-homoserine, D-glucosaminate,
FIG. 1. SDS-PAGE of the enzyme purified from P. putida 24-1
(A) and the recombinant enzyme (B). (A) Lane M, molecular marker
proteins; lane 1, purified enzyme (5 g of protein). (B) Lane M,
molecular marker proteins; lane 2, cell extract of E. coli JM109 (10
g); lane 3, cell extract of the E. coli JM109/pKPSA clone (10 g); lane
4, enzyme purified from E. coli JM109/pKPSA clone cells (1 g).
TABLE 1. Purification of phenylserine aldolase from P. putida 24-1
Step Totalprotein (mg)
Sp act
(U/mg)
Total
activity (U)
Yield
(%)
Crude extract 38,000 0.68 26,000 100
Ammonium sulfate 24,000 1.0 24,000 92
DEAE-cellulose 8,700 2.4 21,000 80
Hydroxyapatite 800 10 8,000 31
2nd DEAE-cellulose 100 47 4,700 18
2nd Hydroxyapatite 29 130 3,800 15
Mono Q 9.0 300 2,700 10
TABLE 2. Substrate specificity of phenylserine aldolase
Amino acid kcat (s1) Km (mM) kcat/Km (M1 s1)
L-threo-3-Phenylserine 2,300 1.3 1,800
D-threo-3-Phenylserine 0
L-erythro-3-Phenylserine 7,900 4.6 1,700
D-erythro-3-Phenylserine 0
L-Threonine 580 29 20
L-allo-Threonine 1,300 22 59
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D-mannosamine, D-glucosamine, or D-galactosamine. No
SHMT activity of the enzyme was detected.
Inhibitors. The enzyme was inactivated 52% by 1 mM phe-
nylhydrazine, 97% by 1 mM hydroxylamine, 98% by 1 mM
D-cycloserine, and 97% by 1 mM semicarbazide, which are
typical inhibitors of the vitamin B6 enzymes. The enzyme,
however, was not inactivated by 0.1 mM p-chloromercuriben-
zoate, 0.1 mM HgCl2, or 1 mM monoiodoacetate. The enzyme
activity was not influenced by 1 mM EDTA, 1 mM ,-dipyri-
dyl, 1 mM 1,10-phenanthroline, 50 mM cations (such as KCl,
NaCl, NH4Cl, RbCl, LiCl, and CsCl), and 0.1 mM metal so-
lutions [such as Al2(SO4)3, BaCl2, MgCl2, MnCl2, ZnCl2,
CuSO4, NiSO4, LiSO4, CoSO4, and FeSO4]. The enzyme was
inhibited by 20 mM DL-3-hydroxyphenylethylamine (79%), 20
mM DL-3-hydroxynorvaline (49%), 10 mM L-3-phenyllactate
(39%), 20 mM DL-3-hydroxy-n-butyrate (30%). DL-3-Hydroxy-
phenylethylamine showed a competitive inhibition (Ki, 4.1
mM) against DL-threo-3-phenylserine. L-Serine, D-alanine, gly-
cine, L-phenylalanine, and 2-amino-3-phenylbutanoate (10
mM) did not inhibit the reaction.
Reversibility of the enzyme reaction. The enzyme catalyzed
the reverse reaction, synthesis of L-3-phenylserine from a mix-
ture of glycine and benzaldehyde. Analysis of the reaction
mixture by HPLC with a TSK gel Enantio L1 column revealed
that the products were a mixture of L-threo-3-phenylserine and
L-erythro-3-phenylserine (2:1) (Fig. 2). The optimum pH for
the synthesis of 3-phenylserine isomers from glycine and ben-
zaldehyde was about 7.5. The best result was obtained at the
ratio of glycine to benzaldehyde of 10:1 (mol/mol) at pH 7.5,
though the Km values for glycine and benzaldehyde could not
be determined. The synthetic reaction rate (4.3 mol/min/mg
of protein), however, was 70-fold less than the cleavage reac-
tion rate of L-threo-3-phenylserine (300 mol/min/mg of pro-
tein).
Cofactor. The enzyme exhibited the absorption maxima at
280 and 420 nm at pH 7.4 (Fig. 3). No appreciable spectral shift
occurred upon variation of the pH (6.0 to 9.5). Reduction of
the enzyme with 5 mM sodium borohydride by the dialysis
method of Matsuo and Greenberg (22) affected both the ab-
sorption spectrum (Fig. 3) and the activity. The 420-nm peak
disappeared with the appearance of an absorption peak at 330
nm, and the reduced enzyme was catalytically inactive in the
absence of PLP. These results showed that borohydride re-
duced the aldimine linkage to yield the aldimine bond. The
addition of 20 M PLP to the reduced enzyme showed activity
(about 30% of the activity obtained by the native enzyme in the
presence of 20 M PLP). The activity of the native enzyme was
increased about 30% by the addition of 20 M PLP. These
results showed that about 30% of the bound PLP was released
from the enzyme. The PLP content of the enzyme was 0.74
mol/38,000 g of protein by the phenylhydrazine method (35)
and 0.69 mol/38,000 g of protein by the cyanohydrin method
(1). The results obtained by these two procedures suggest that
0.7 mol of PLP is bound to 1 mol of the subunit of the enzyme
and 30% of the enzyme is an apo form. To obtain the apoen-
zyme, the enzyme was incubated with 10 mM hydroxylamine in
the presence of 0.1 M potassium phosphate buffer (pH 7.2) at
30°C for 20 min, followed by dialysis against 10 mM TES buffer
(pH 7.2) containing 0.01% 2-mercaptoethanol. The enzyme
thus treated had no activity in the absence of added PLP and
no longer exhibited an absorption maximum at 420 nm (Fig. 3).
Activity was almost fully restored by the addition of 20 M
PLP. Pyridoxal, pyridoxamine, pyridoxine, pyridoxamine 5
phosphate, and pyridoxine 5 phosphate neither restored the
activity nor acted as inhibitors. The Michaelis constant for PLP
was estimated to be 31 nM. The active enzyme reconstituted
with PLP showed an absorption maximum at 420 nm. These
data suggest that PLP is an essential cofactor of the enzyme.
Amino acid sequence of the enzyme and peptides obtained
by tryptic digestion of the enzyme from P. putida 24-1. The
N-terminal amino acid sequence of the enzyme was not ob-
FIG. 2. Formation of L-threo-3-phenylserine and L-erythro-3-phe-
nylserine from glycine and benzaldehyde. The reverse reaction was
carried out as described in Materials and Methods. The reaction mix-
ture was analyzed with a TSK gel Enantio L1 column. (A) Standard
3-phenylserine; (B) reaction mixture. Peaks: 1, D-threo-3-phenylserine;
2, D-erythro-3-phenylserine; 3, L-threo-3-phenylserine; 4, L-erythro-3-
phenylserine.
FIG. 3. Absorption spectrum of the enzyme. Absorption spectra
were taken with a Hitachi 220A spectrophotometer. The enzyme (1
mg/ml) in 10 mM TES buffer (pH 7.2) was used. Curve A, native
enzyme; curve B, NaBH4-reduced enzyme; curve C, apoenzyme.
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tained by the Edman degradation method. Thus, the amino
acid sequences of five peptides (P1 to P5) obtained from the
tryptic digest of the enzyme and the C-terminal peptide (P6) of
the enzyme were determined with a protein sequencer. These
sequences are shown in Fig. 4.
Cloning and sequencing of the gene encoding the phenyl-
serine aldolase from P. putida 24-1. The structural gene for the
enzyme was isolated from a plasmid pool containing SphI
fragments of P. putida. A positive clone was selected from
about 700 transformants by colony hybridization as described
in Materials and Methods. The plasmid (pPSA) isolated from
the positive clone had an about 6.7-kb fragment of the P.
putida chromosomal DNA in the SphI site of pUC19. The
nucleotide sequence of the fragment showed an open reading
frame consisting of 1,074 nucleotides, starting with an ATG
codon (Fig. 4). The putative Shine-Dalgarno sequence was
located 7 bases upstream from the codon. The amino acid
sequences of five internal peptides (P1 to P5) isolated from the
tryptic digest of the enzyme from P. putida 24-1 and the C-
terminal peptide (P6) were in good agreement with the pre-
dicted amino acid sequence (Fig. 4). The N-terminal amino
acid should be Asn, because the N-terminal methionine was
not detected and the Asn-Gly sequence was sometimes not
subjected to Edman degradation. The calculated molecular
mass of this protein was 37,400 Da, which agreed with the
apparent subunit molecular mass (38 kDa) of the enzyme pu-
rified from P. putida 24-1. E. coli cells harboring pPSA showed
activity (0.06 units per mg protein), which was independent of
the IPTG added to the medium. However, high activity (2.5
units per mg of protein) was obtained by the addition of 0.2%
DL-threo-3-phenylserine in the medium. L-Threonine and L-
allo-threonine did not influence gene expression. This suggests
that the plasmid pPSA contains the regulatory gene together
with the structural gene for the enzyme. The structural gene
for the enzyme was amplified by PCR and ligated into the
EcoRI-HindIII site of pKK223-3 to obtain a high-expression
strain. E. coli cells containing the constructed plasmid pKPSA
produced a high level of the enzyme (41 units per mg of
protein) without the addition of 0.2% DL-threo-3-phenylserine
to the medium.
Purification of the recombinant enzyme from E. coli clone
cells. The recombinant enzyme was purified from E. coli cells
harboring pKPSA by three steps with a 20% yield as described
in Materials and Methods. The purified enzyme showed a
single band on SDS-PAGE (Fig. 1B). The enzymologic prop-
erties, such as optimum pH (pH 8.5), substrate specificity, and
an apparent Km value (1.3 mM) for L-threo-3-phenylserine, of
the recombinant enzyme were almost the same as those of the
enzyme purified from P. putida 24-1. The recombinant enzyme
FIG. 4. Nucleotide sequence of the structural gene encoding the phenylserine aldolase from P. putida 24-1 and the deduced amino acid
sequence. The amino acid sequences that were determined by Edman degradation of the peptides isolated from the tryptic digest of the enzyme
are indicated by single underlining. The putative ribosome binding sequence is shown by bold underlining, and the stop codon is indicated with
an asterisk.
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and E. coli cloned cells catalyzed the reverse reaction, as did
the P. putida enzyme.
Identification of the active-site lysine residue. To identify
the PLP-binding lysine residue of the enzyme, two mutant
enzymes, K213Q and K238Q, were constructed and purified
as described in Materials and Methods. The K213Q mutant
enzyme showed no detectable activity, and the K238Q mu-
tant enzyme showed about 92% activity of the wild-type
enzyme. The K238Q enzyme showed an absorption maxi-
mum at 420 nm, but the K213Q enzyme did not show the
absorption maximum at 420 nm. These suggest that a Schiff
base linkage between PLP and the ε-amino group of the
active-site lysine residue in the wild-type enzyme is not in
the K213Q enzyme.
DISCUSSION
P. putida 24-1 could utilize L-threo-3-phenylserine as a sole
carbon and nitrogen source. The bacterium produces phenyl-
serine aldolase, which catalyzes the cleavage of L-threo-3-phe-
nylserine to yield glycine and benzaldehyde. The enzyme pro-
duction was induced by L-threo-3-phenylserine but not by
L-threonine and L-allo-threonine, suggesting that the enzyme
functions in the degradation of L-threo-3-phenylserine. We
have purified and characterized phenylserine aldolase from P.
putida 24-1 to compare its properties with those of SHMT and
threonine aldolases. Phenylserine aldolase from P. putida 24-1
was a hexamer, as was the threonine aldolase from Candida
humicola (10). Although L-allo-threonine aldolase (13), the
FIG. 5. Linear alignment of amino acid sequences of amino acid aldolases. Pp, phenylserine aldolase from P. putida 24-1; Ps, low-specificity
L-threonine aldolase from Pseudomonas sp. (16); Ec, low-specificity L-threonine aldolase from E. coli (15); Tm, low-specificity L-threonine aldolase
from Thermotoga maritima (8); Ca, low-specificity L-threonine aldolase from Candida albicans (23); Sc, low-specificity L-threonine aldolase from
Saccharomyces cerevisiae (17); Aj, L-allo-threonine aldolase from Aeromonas jandaei (13). Gray shading indicates residues identical among the
seven sequences. The asterisk shows the lysine residue forming a Schiff base with PLP.
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low-specificity L-threonine aldolase (14–17), and SHMT (25)
acted on L-threo-3-phenylserine and L-erythro-3-phenylserine,
these enzymes were tetramers, except for the E. coli SHMT (a
dimer) (31). Good substrates of the phenylserine aldolase from
P. putida 24-1 were L-threo-3-phenylserine and L-erythro-3-phe-
nylserine (Table 2). The enzyme did not show SHMT activity
and was not inhibited by D-alanine, though SHMTs were in-
hibited by D-alanine (25, 27, 28, 30). The reactivities (kcat/Km)
of the phenylserine aldolase from P. putida 24-1 for L-threo-
phenylserine and L-erythro-phenylserine were much higher
than those of L-allo-threonine aldolase (13) and low-specificity
threonine aldolases (14–17). L-allo-Threonine aldolase did not
act on L-threonine (13). Threonine aldolase from C. humicola
was activated by K and NH4
 (10). The enzyme from P.
putida 24-1, however, was not activated by these ions. These
results described above show that the enzyme from P. putida
24-1 is different from L-allo-threonine aldolase (13), L-threo-
nine aldolases (14–17), and SHMTs (27, 28, 30, 31).
The amino acid sequence of the enzyme from P. putida 24-1
was similar to those of other amino acid aldolases (Fig. 5). The
percentages of identical amino acids of the enzyme compared
with the low-specificity L-threonine aldolases from Pseudomo-
nas sp. strain NCIMB 10558 (16), E. coli (15), Thermotoga
maritima (8), Candida albicans (23), and Saccharomyces cerevi-
siae (17) and with the L-allo-threonine aldolase from Aeromo-
nas jandaei (13) were estimated to be 44, 22, 22, 21, 21, and
21%, respectively. Y40, H94, H139, H178, R183, K213, K238,
and R328 were conserved in these enzymes (Fig. 5).
PLP functions as a cofactor for a wide range of enzyme-
catalyzed reactions, including retroaldol reactions and aldol
condensations, and the cofactor’s intrinsic chemical properties
are modulated and enhanced at the respective enzyme active
site. The phenylserine aldolase from P. putida 24-1 contained
bound PLP and showed an absorption peak at 420 nm. The
characteristic spectral change of the enzyme upon NaBH4 re-
duction (Fig. 3) suggests that PLP is bound to an ε-amino
group of a lysine residue of the protein through an aldimine
linkage, as reported for other vitamin B6 enzymes (8, 28). K213
of the P. putida enzyme was shown to be a catalytic residue that
formed a Schiff base with PLP by site-directed mutagenesis.
Liu et al. (13) also showed that K199 of L-allo-threonine aldo-
lase from A. jandaei (corresponding to K213 of the P. putida
enzyme) was the PLP-binding residue by site-directed mu-
tagenesis. X-ray analysis of the low-specificity L-threonine al-
dolase from T. maritima showed that PLP was bound to K199
(corresponding to K213 of the P. putida enzyme) via a Schiff
base linkage and that H83, R171, and R316 were important
residues in the catalysis (8). These residues were conserved in
the P. putida enzyme. The catalytic mechanism of the enzyme
from P. putida 24-1 should be similar to that of threonine
aldolase (8). In the cleavage reaction of 3-phenylserine, the
amino group of 3-phenylserine should form an external aldi-
mine (a PLP substrate imine) with the PLP cofactor, which is
bound via a Schiff base linkage to the ε-amino group of the
active-site lysine residue (an internal aldimine). Next, the
cleavage of the 3-phenylserine aldimine produces benzalde-
hyde and the PLP-glycine quinonoid complex. Following pro-
tonation of the glycine -carbon, glycine is released, regener-
ating the internal aldimine with the active-site lysine residue.
The coenzyme acts as an electron sink, storing electrons from
cleaved substrate bonds and dispensing them for the formation
of new linkages with incoming protons or second substrates.
It is assumed that enzymes showing the aldolase activity for
3-hydroxy-2-amino acids, including threonine aldolase (8), pos-
sess a general base which will interact with the 3-hydroxy group
at the active site. In the phenylserine aldolase, the affinity for
the threo form of the substrate amino acid was about three
times higher than that for the erythro form, suggesting that
L-threo-3-phenylserine is a most suitable substrate for the ac-
tive-site structure. In addition, the fact that, in the reverse
reaction (i.e., the synthesis of 3-phenylserine from glycine and
benzaldehyde), the yield of the threo form was about twofold
higher than that of the erythro form probably reflects the bind-
ing property of the general base to the 3-hydroxy group. The
identification and alteration (or modification) of the general
base may lead to the improvement of enzymatic 3-phenylserine
synthesis. For example, the engineered enzyme and the en-
zyme-overproducing E. coli cloned cells have potential for the
synthesis of useful L-threo-3-phenylserine and its derivatives
such as L-threo-3-[4-(methylthio)-phenylserine], which is a key
intermediate for the synthesis of the antibiotics florfemicol and
thiamphenicol (19). Resolution of the tertiary structure of the
useful enzyme and especially detailed analyses of the region
interacting with the functional groups on the three positions of
the substrate will provide insight into developing strategies for
enzyme engineering and application.
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